"Amphetamines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Analogs or derivatives of AMPHETAMINE. Many are sympathomimetics and central nervous system stimulators causing excitation, vasopressin, bronchodilation, and to varying degrees, anorexia, analepsis, nasal decongestion, and some smooth muscle relaxation.
Descriptor ID |
D000662
|
MeSH Number(s) |
D02.092.471.683.152
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Amphetamines".
Below are MeSH descriptors whose meaning is more specific than "Amphetamines".
This graph shows the total number of publications written about "Amphetamines" by people in this website by year, and whether "Amphetamines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2007 | 0 | 1 | 1 |
2017 | 0 | 1 | 1 |
2018 | 3 | 0 | 3 |
2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Amphetamines" by people in Profiles.
-
False positive amphetamines and 3,4-methylenedioxymethamphetamine immunoassays in the presence of metoprolol-two cases reported in clinical toxicology. J Anal Toxicol. 2020 Mar 07; 44(2):200-205.
-
Simultaneous Determination of Amphetamine-Related New Psychoactive Substances in Urine by Gas Chromatography-Mass Spectrometry. J Anal Toxicol. 2018 Nov 01; 42(9):605-616.
-
An Unusual Case of Hearing Loss. J Emerg Med. 2018 09; 55(3):411-414.
-
DARK Side of Amphetamine and Analogues: Pharmacology, Syndromic Manifestation, and Management of Amphetamine Addiction. ACS Chem Neurosci. 2018 10 17; 9(10):2299-2303.
-
Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine. CNS Drugs. 2017 Mar; 31(3):199-215.
-
ultra-long-acting beta2-adrenoceptor agonists: an emerging therapeutic option for asthma and COPD? Drugs. 2007; 67(4):503-15.